Product image of Hemafer-S (Iron) supplied by GNH India

Hemafer-S

Active Ingredient:
Iron
Origin:
EU

Hemafer-S (Iron)

Hemafer-S is an intravenous iron supplement containing elemental iron as its active ingredient. It is supplied as a sterile solution for intravenous administration and is prescribed in the European Union for the treatment of iron deficiency anemia. As a prescription‑only product, Hemafer‑S provides iron directly to the bloodstream to support hemoglobin synthesis and replenish depleted iron stores.

Manufacturer / TM Owner

Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Hemafer‑S is indicated for patients who require rapid correction of iron deficiency anemia, particularly when oral iron therapy is ineffective or not tolerated. It is commonly used in clinical settings such as hospitals and infusion centers.

  • Treatment of iron deficiency anemia in adults
  • Management of anemia associated with chronic kidney disease
  • Support for patients undergoing major surgery or chemotherapy
  • Rapid repletion of iron stores before elective procedures
  • Use in patients with malabsorption syndromes where oral iron is inadequate

Side Effects

Side effects of Hemafer‑S may vary in frequency and severity. Patients should be monitored for any adverse reactions during and after infusion.

Common

  • Transient headache
  • Nausea or vomiting
  • Mild infusion site reactions (e.g., erythema, warmth)
  • Dizziness or light‑headedness
  • Low‑grade fever
  • Muscle cramps

Serious

  • Anaphylactic or severe hypersensitivity reactions
  • Hypotension or cardiovascular collapse
  • Acute respiratory distress
  • Severe hypertension
  • Cardiac arrhythmias

Precautions & Warnings

Before initiating Hemafer‑S therapy, clinicians should assess patient history and current health status. The following precautions are recommended:

  • Verify iron deficiency through laboratory testing before administration
  • Use caution in patients with a history of allergic reactions to intravenous iron products
  • Monitor vital signs during infusion, especially in patients with cardiovascular disease
  • Adjust infusion rate if hypotension or hypertension occurs
  • Avoid use in patients with active infections until resolved
  • Consider renal and hepatic function when determining suitability
  • Ensure appropriate resuscitation equipment is available during infusion

Avoid Interactions

Hemafer‑S may interact with other medications or substances. Awareness of potential interactions can help minimize risks.

Avoid

  • Concurrent administration of other intravenous iron formulations
  • Use with high‑dose vitamin C or ascorbic acid supplements during infusion, which may increase free iron levels

Use with caution

  • Anticoagulants or antiplatelet agents (may increase bleeding risk)
  • Antibiotics such as quinolones (potential for reduced efficacy)
  • Calcium‑containing solutions (may affect iron absorption)
  • Medications that cause hypotension (e.g., antihypertensives)
  • Immunosuppressive agents (monitor for infection risk)

Frequently Asked Questions

Hemafer‑S is an intravenous iron solution that delivers elemental iron directly into the bloodstream, supporting hemoglobin synthesis and replenishing iron stores in patients with iron deficiency anemia.

It is prescribed when rapid correction of iron deficiency anemia is needed, especially if oral iron is ineffective, not tolerated, or when a quick increase in iron stores is clinically required.

Yes, Hemafer‑S is often used to manage anemia associated with chronic kidney disease, providing an intravenous route that bypasses gastrointestinal absorption issues.

Common side effects include headache, nausea, mild infusion site reactions, dizziness, low‑grade fever, and muscle cramps.

Serious reactions can include anaphylaxis, severe hypotension or hypertension, respiratory distress, cardiac arrhythmias, and other hypersensitivity responses.

Clinicians should confirm iron deficiency through labs, review allergy history, monitor vital signs during infusion, and assess cardiovascular, renal, and hepatic status.

Yes, concurrent use of other IV iron formulations should be avoided to prevent excess iron exposure and related toxicity.

High‑dose vitamin C taken during infusion can increase free iron levels and should be avoided to reduce the risk of oxidative stress.

Anticoagulants may increase bleeding risk; therefore, they should be used with caution and under close medical supervision during Hemafer‑S treatment.

Patients should be observed for immediate adverse reactions, vital signs should be checked, and follow‑up labs are typically performed to assess hemoglobin and iron parameters.

The pregnancy safety category for Hemafer‑S is not established; clinicians should weigh potential benefits against risks and consider alternative therapies when possible.

The infusion should be stopped immediately, and emergency medical treatment, including administration of epinephrine and supportive care, should be provided.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.